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nary sinus (lead screwed inside the Cs at 1 to 2 cm from the ostium). All
patients were in sinus rhythm with an IACD defined as a p wave prolongation
greater than 120ms in lead II, normal QRS interval. None of them had a stan-
dard indication for pacemaker implantation.
This double-blind, randomized, crossover study compared the responses of
the patients during two periods: a two-week period of inactive pacing (ventric-
ular inhibited pacing at a basic rate of 30 bpm) and a two-week period of
active (left atrial permanent pacing). The primary end point was the distance
walked in six minutes (6MWD). The secondary endpoint was the patient’s
treatment preference.
Results: During the inactive phase, two patients developed an acute heart
failure few hours after the pacemaker was turned off. The mean (±SD) dis-
tance walked in six minutes was 21 percent greater with active pacing
(237±30 m vs. 187±18 m, P<0.001). Active pacing was preferred by 100 per-
cent of the patients.
Conclusions: Although the beneficial effects of left atrial permanent pacing
need to be confirmed by a larger study, this new pacing strategy may improve
exercise tolerance in patients with HFPEF and short left atrio-ventricular interval.
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Introduction: Out of proportion post-capillary pulmonary hypertension
(resulting from left-sided heart failure, group 2 of the World Health Organisation
of Pulmonary Hypertension (PH) classification.) is a well known hemodynamic
entity described in the past in mitral stenosis, but also concern patients with left-
side heart failure and preserved ejection fraction (HFpEF). The prevalence is prob-
ably underestimated because a part of this population is addressed to the PH center
and misdiagnosed group 1 PH of WHO classification.
Methods and results: From 2008 to 2011, we operate 1541 right heart
catheterization and 454 were addressed form the PH center for evaluation. We
identified 21 patients with out of proportion group 2 pulmonary hypertension
and HFpEF. We determine the clinical, echographic and hemodynamic char-
acteristics of these patients.
These patients are old (median =71 years, 67 to 77), more often female
(15/21), with history of hypertension (20/21), mellitus diabete (14/21), obesity
(16/21), atrial fibrillation (13/21), renal dysfunction (12/21) and a high preva-
lence of cardiovascular events.
In echocardiography, the ejection fraction is preserved (EF>50%), the sys-
tolic pulmonary arterial pressure is elevated (median=64 mmHg) and the right
chambers are dilated (14/21) with elevation of the end-diastolic left side pres-
sure and enlargement of the left atrial.
The right heart catheterization revise the diagnosis, sometimes only after
filling test when capillary pulmonary (Pcap) is close to 15 mmHg. The PAPd-
Pcap gradient (<10 mmHg) is more relevant (100% in our population) than the
classic trans-pulmonary gradient to guide to the diagnosis of group 2 PH.
Conclusion: There is concern that out of proportion post-capillary hyper-
tension associated with HFpEF may often be misclassified as having WHO
group 1 PH. The distinction is particularly important as therapies indicated in
group 1 PH can be deleterious in group 2 PH.
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Background: Heart failure with preserved ejection fraction (HFpEF) is
equally common as reduced EF, but clinical characteristics and prognosis
remain incompletely defined. There are differences in HFpEF definition and
prognosis in clinical trials versus epidemiological surveys.
Methods: The rationale for the multinational Karolinska-Rennes (KaRen)
prospectiveobservational study has been desribed. Patients presenting with
acute heart failure (HF) were screened in 14 university hospitals. Inclusion cri-
teria were: Framingham criteria for HF and left ventricular EF-45%and NT-
proBNP > 300pg/ml. Once stabilized, 4-8 weeks after the index visit, patients
were reevaluated and prospectively followed.
Results : Between 2007 and 2010, 478 patients were included. 42% were
males. Female are older (78±9 vs 75±10, p=0.0009); faster (heart rate 87±55
vs 79±23, p=0.0001). Mean age was 77±16 years, body mass index 29±19 kg/m²,
left ventricular EF 56±14% (57±17 for female vs 55±17, p=0.001), and NT-
proBNP decreased from 3958±4534 to 2001±1949 pg/ml from inclusion to the
4-8 weeks visit (p<0.01), but 27% of the patients were still NYHA III to IV
at second visit. Six-month mortality was 8%. Table I displays baseline char-
acteristics.
Conclusion
In a prospective registry of HFPEF, patients are similar to that described in
epidemiological studies, and mortality is similar to reduced EF. Patients are
old, and remain symptomatic. Predictors of prognosis cause of death and tar-
gets of intervention will be presented.
Table I – Main results (abstract 099) 
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84±29/min 12.9±7.9 109.7±62.2 61.9±30.5 49% IV–
41% III–
10% I-II
80% 
NYHA I-II
60% 10.5% 27.5%
